Pregled bibliografske jedinice broj: 1175045
A new glimpse on the active site of SARS-CoV-2 3CLpro, coupled with drug repurposing study
A new glimpse on the active site of SARS-CoV-2 3CLpro, coupled with drug repurposing study // Molecular diversity, 26 (2022), 5; 2631-2645 doi:10.1007/s11030-021-10355-8 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1175045 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
A new glimpse on the active site of SARS-CoV-2 3CLpro, coupled with drug repurposing study
Autori
Novak, Jurica ; Potemkin, Vladimir A.
Izvornik
Molecular diversity (1381-1991) 26
(2022), 5;
2631-2645
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
3CLpro ; COVID-19 ; drug repurposing ; paritaprevir ; QSAR ; radial distribution function
Sažetak
Coronavirus disease 2019 (COVID-19) is caused by novel severe acute respiratory syndrome coronavirus (SARS-CoV-2). Its main protease, 3C-like protease (3CLpro), is an attractive target for drug design, due to its importance in virus replication. The analysis of the radial distribution function of 159 3CLpro structures reveals a high similarity index. A study of the catalytic pocket of 3CLpro with bound inhibitors reveals that the influence of the inhibitors is local, perturbing dominantly only residues in the active pocket. A machine learning based model with high predictive ability against SARS-CoV-2 3CLpro is designed and validated. The model is used to perform a drug-repurposing study, with the main aim to identify existing drugs with the highest 3CLpro inhibition power. Among antiviral agents, lopinavir, idoxuridine, paritaprevir, and favipiravir showed the highest inhibition potential. Enzyme - ligand interactions as a key ingredient for successful drug design.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE